Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi’s sarcoma

References

• EngelsEABiggarRJMarshallVADetection and quantitation of Kaposi’s sarcoma associated herpes virus to predict AIDS associated Kaposi’s sarcomaAIDS2003171847185112891072
   PubMed Web of Science ®Google Scholar
• ChangYCesarmanEPessinMSIdentification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcomaScience1994266186518697997879
   PubMed Web of Science ®Google Scholar
• MoorePSGaoSJDominguezGPrimary characterization of a herpesvirus agent associated with Kaposi’s sarcomaJ Virol1996705495588523568
   PubMed Web of Science ®Google Scholar
• CesarmanEChangYMoorePSKaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomasN Engl J Med1995332118611917700311
   PubMed Web of Science ®Google Scholar
• SoulierJGrolletLOskenhendlerEKaposi’s sarcoma–associated herpesvirus-like DNA sequences in multicentric Castleman’s diseaseBlood199586127612807632932
   PubMed Web of Science ®Google Scholar
• BiggarRJChaturvediAKGoedertJJEngelsEAHIV/AIDS Cancer Match StudyAIDS-related cancer and severity of immunosuppression in persons with AIDSJ Natl Cancer Inst2007991296297217565153
   PubMedGoogle Scholar
• GoedertJJThe epidemiology of acquired immunodeficiency syndrome malignanciesSemin Oncol20002739040110950365
   PubMed Web of Science ®Google Scholar
• Cook-MozaffariPNewtonRBeralVThe geographical distribution of Kaposi’s sarcoma and of lymphomas in Africa before the AIDS epidemicBr J Cancer199878152115289836488
   PubMed Web of Science ®Google Scholar
• SitasFNewtonRKaposi’s sarcoma in South AfricaJ Natl Cancer Inst Monog20012814
   PubMedGoogle Scholar
• CheungMCPantanowitzLDezubeBJAIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapyOncologist200510641242615967835
   PubMed Web of Science ®Google Scholar
• IoachimHLAdsayVGiancottiFRKaposi’s sarcoma of internal organs. A multiparameter study of 86 casesCancer199575137613857882289
   PubMed Web of Science ®Google Scholar
• DezubeBJPantanowitzLAboulafiaDMManagement of AIDS-related Kaposi sarcoma: advances in target discovery and treatmentAIDS Read20041423623824324425125315199854
   PubMedGoogle Scholar
• SchiffNFAnninoDJWooPKaposi’s sarcoma of the larynxAnn Otol Rhinol Laryngol19971065635679228856
   PubMed Web of Science ®Google Scholar
• HuangLSchnappLMGrudenJFPresentation of AIDS-related pulmonary Kaposi’s sarcoma diagnosed by bronchoscopyAm J Respir Crit Care Med1996153138513908616570
   PubMed Web of Science ®Google Scholar
• DezubeBJAcquired immunodeficiency syndrome related Kaposi’s sarcoma: clinical features, staging, and treatmentSemin Oncol20002742443010950369
   PubMed Web of Science ®Google Scholar
• RealFXKrownSESpontaneous regression of Kaposi’s sarcoma in patients with AIDSN Engl J Med198531316594069179
   PubMed Web of Science ®Google Scholar
• CoukellASpencerCMPolyethylene glycol-liposomal doxorubicin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi’s sarcomaDrugs19975335205389074848
   PubMed Web of Science ®Google Scholar
• HaranGCohenRBarLKTransmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak basesBiochim Biophys Acta199010251431512364073
   PubMed Web of Science ®Google Scholar
• LasicDDFrederkPMStuartMCAGelation of liposome interior. A novel method for drug encapsulationFEBS Lett19923122552581426260
   PubMed Web of Science ®Google Scholar
• PapahadjopoulosDAllenTGabizonASterically stabilized liposomes: improvements in pharmacokinetics and anti-tumor therapeutic efficacyProc Natl Acad Sci U S A19918811460114641763060
   PubMed Web of Science ®Google Scholar
• BalmerCValleyAWDi PiroJTTalbertRLHayesPEBasic principles of cancer treatment and cancer chemotherapyPharmacotherapy: A pathophysiologic approach2nd edNorwalk, CTAppleton and Lange199318791929
   Google Scholar
• MeriwetherWDBachurNRInhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemiaCancer Res1972326113711425030814
   PubMed Web of Science ®Google Scholar
• HortobágyiGNAnthracyclines in the treatment of cancerDrugs199754Suppl 417
   PubMed Web of Science ®Google Scholar
• SpeyerJWasserheitCStrategies for reduction of anthracycline cardiac toxicitySemin Oncol19982555255379783592
   PubMed Web of Science ®Google Scholar
• StürzlMZietzCEisenburgBLiposomal doxorubicin in the treatment of AIDS-associated Kaposi’s sarcoma: clinical, histological and cell biological evaluationRes Virol19941453–42612697800953
   PubMedGoogle Scholar
• SharpeMEasthopeSEKeatingGMLambHMPolyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi’s sarcomaDrugs200262142089212612269857
   PubMed Web of Science ®Google Scholar
• SimpsonJKMillerRFSpittleMFLiposomal doxorubicin for treatment of AIDS-related Kaposi’s sarcomaClin Oncol19935372374
   PubMedGoogle Scholar
• HarrisonMTomlinsonDStewartSLiposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi’s sarcomaJ Clin Oncol1995139149207707119
   PubMed Web of Science ®Google Scholar
• NorthfeltDWDezubeBJThommesJAPegylated liposomal doxorubicin versus doxorubicin, bleomycin and vincristine in the treatment of AIDS-related Kaposi’s sarcoma: results of a randomized phase III clinical trialJ Clin Oncol199816244524519667262
   PubMed Web of Science ®Google Scholar
• StewartSJablonowskiHGoebelFDRandomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi’s sarcomaJ Clin Oncol1998166836919469358
   PubMed Web of Science ®Google Scholar
• NorthfeltDWDezubeBJThommesJAEfficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma after failure of standard chemotherapyJ Clin Oncol1997156536599053490
   PubMed Web of Science ®Google Scholar
• Martin-CarboneroLBarriosASaballsPPegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi’s sarcomaAIDS200418121737174015280789
   PubMed Web of Science ®Google Scholar
• LichterfeldMQurishiNHoffmannCTreatment of HIV-1-associated Kaposi’s sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recoveryInfection20053314014715940415
   PubMed Web of Science ®Google Scholar
• GoebelFDGoldsteinDGoosMJablonowskiHStewartJSEfficacy and safety of stealth liposomal doxorubicin in AIDS-related Kaposi’s sarcoma. The International SL-DOX Study GroupBr J Cancer1996739899948611437
   PubMed Web of Science ®Google Scholar
• HenggeUREsserSRudelHPGoosMLong-term chemotherapy of HIV-associated Kaposi’s sarcoma with liposomal doxorubicinEur J Cancer20013787888311313176
   PubMed Web of Science ®Google Scholar
• CooleyTHenryDTondaMSunSO’ConnellMRackoffWA randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi’s sarcomaOncologist20071211412317227906
   PubMed Web of Science ®Google Scholar
• LittleRFAlemanKKumarPPhase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcomaBlood20071104165417117846226
   PubMed Web of Science ®Google Scholar
• Martin-CarboneroLPalaciosRValenciaEthe Caelyx/KS Spanish study groupLong-term prognosis of HIV-infected patients with Kaposi’s sarcoma treated with pegylated liposomal doxorubicinClin Infect Dis20084741041718582203
   PubMed Web of Science ®Google Scholar
• NunezMSaballsPValenciaMEfor the Caelyx/KS Spanish Study GroupResponse to liposomal doxorubicin and clinical outcome of HIV-1–infected patients with Kaposi’s sarcoma receiving highly active antiretroviral therapyHIV Clin Trials2001242943711673818
   PubMedGoogle Scholar
• BillinghamMBristowMEvaluation of anthracycline cardiotoxicity Predictive ability and functional correlation of endomyocardial biopsyCancer Treat Symp198437176
   Google Scholar
• BerryGBillinghamMAldermanEThe use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi’s sarcoma patients treated with pegylated liposomal doxorubicinAnn Oncol199897117169739435
   PubMed Web of Science ®Google Scholar
• OsobaDNorthfeltDWBuddDWEffect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposi’s sarcoma: a randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristineCancer Invest200119657358011486699
   PubMed Web of Science ®Google Scholar
• BennettCLGolubRMStinsonTJCost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi’s sarcomaJ Acquir Immune Defic Syndr1998185460465
   Web of Science ®Google Scholar
• HjortsbergCPersonULidbrinkECost-effectiveness analysis of pegylated-liposomal doxorubicin and liposomal daunorubicin treatments in patients with Kaposi’s sarcomaActa Oncol19993881063106710665764
   PubMed Web of Science ®Google Scholar
• VanniTLopes FonsecaBAPolanczykCACost-effectiveness analysis comparing chemotherapy regimens in the treatment of AIDS-related Kaposi’s sarcoma in BrazilHIV Clin Trials20067419420217065031
   PubMed Web of Science ®Google Scholar
• IscovichJBoffettaPBrennanPClassic Kaposi’s sarcoma as a first primary neoplasmInt J Cancer1999801731779935195
   PubMed Web of Science ®Google Scholar
• BowerMCollinsSCottrillCBritish HIV Association guidelines for HIV-associated malignancies 2008HIV Med2008933638818705759
   PubMed Web of Science ®Google Scholar